Accueil
Détail de l'auteur
Documents disponibles écrits par cet auteur (247)
Ajouter le résultat dans votre panier Faire une suggestion Affiner la recherche
Chapitre
OEDT = EMCDDA | 2012FRANÇAIS : En Europe et dans le monde, les nouvelles drogues et les nouveaux modes de consommation attirent de plus en plus l'attention du monde politique, des médias et du public. Cette situation s'explique, en partie, par les évolutions des t[...]Document multimédia
FRANÇAIS : Ce mini-guide s'inscrit dans le cadre plus vaste du document intitulé "Réponses sanitaires et sociales apportées aux problèmes de drogue : un guide européen". Il fournit une vue d'ensemble des aspects les plus importants à prendre en[...]Rapport
FRANÇAIS : Ce court rapport (« snapshot ») porte sur la vente en ligne de nouvelles substances psychoactives. Alors que 170 magasins en ligne vendant de nouvelles substances psychoactives (« legal high ») et livrant à au moins un pays membre de[...]Document multimédia
This miniguide is one of a larger set, which together comprise Health and social responses to drug problems: a European guide. It provides an overview of the most important aspects to consider when planning or delivering health and social respon[...]Rapport
This report presents an analysis of the drug markets in the European Neighbourhood Policy-East region covering Armenia, Azerbaijan, Belarus, Georgia, Moldova and Ukraine. Focused on providing insights into drug production, trafficking, sale, use[...]Rapport
This report presents an analysis of the drug markets in the European Neighbourhood Policy-South region covering Algeria, Egypt, Israel, Jordan, Lebanon, Libya, Morocco, Palestine, Syria and Tunisia. Focused on providing insights into drug produc[...]Document multimédia
The use of mass media campaigns as a drug prevention intervention is relatively common, but it is not without controversy. Both policymakers and practitioners have debated the effectiveness of such campaigns in reducing drug use among young peop[...]Document multimédia
The European market for hashish is currently one of the world's largest and most profitable. About 647 tons of cannabis herb and 641 tons of hashish were consumed in the European Union in 2013 and the retail market has an overall value estimated[...]Document multimédia
Cannabis is Europe's most commonly used illicit drug, with approximately 20 million adults, or around 6% of the population aged 15-64 years, having used the drug in the last year. An indication of the public health impact of the drug can be seen[...]Document multimédia
Cocaine is Europe's most commonly used illicit stimulant drug, with about 3.6 million adults (aged 15-64) estimated to have used it in the last year. It is the second most seized drug in Europe, after cannabis. Cocaine is trafficked to Europe fr[...]Document multimédia
Comorbidity of substance use and mental health disorders refers to the co-occurrence of a substance use disorder and another mental health disorder in the same individual. In Europe, the presence of psychiatric disorders associated with substanc[...]Document multimédia
FRANÇAIS : Les salles de consommation de drogues à moindre risque dans lesquelles des drogues illicites peuvent être consommées sous la supervision de personnel qualifié, existent en Europe depuis une trentaine d'années. Ces infrastructures ont[...]Document multimédia
Every year, several thousands of cocaine-related emergencies are reported in Europe, along with hundreds of cocaine-related deaths. The types of cocaine-related problems reported are wide-ranging and the relatively high prevalence of cocaine use[...]Document multimédia
Methamphetamine is an established stimulant drug in many parts of the world (e.g. South-east Asia, US), where it has long caused major public health problems. While methamphetamine use in Europe has historically been confined to the Czech Republ[...]Document multimédia
The emergence of new psychoactive substances (NPS) over the last decade has posed a major challenge to drug policy. While the limited available data indicates that prevalence levels of NPS use are relatively low in the general European populatio[...]